Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. QuVa Pharma, Inc.
483
•QuVa Pharma, Inc.•August 18, 2022

QuVa Pharma, Inc. – FDA 483, Aug 18, 2022

Record Details

An FDA Form 483 was issued to a drug product manufacturing facility following an inspection. The facility produces drug products including Cefazolin PF and Methoietheal Sodium 100mg/10 mL PF.

Three observations were noted:

1. **Lack of Employee Training:** On July 27, 2022, an EM Technician and a Compounding Technician were observed failing to follow proper sterile gowning procedures in the ISO 8 Anteroom before entering the ISO 7 Cleanroom. The EM Technician touched the outside of the gown and a cart, while the Compounding Technician failed to adjust shoe covers. The firm's Sterility Assurance Manager intervened. This indicates a deficiency in training for employees performing critical manufacturing and processing functions.

2. **Deficient Finished Product Conformance Determinations:** On July 12, 2022, finished drug products, Methoietheal Sodium 100mg/10 mL PF, Lot Numbers (b) (4) and (b) (4), were found at room temperature in the (b) (4) Laboratory awaiting receipt, despite the product label specifying refrigeration. The Laboratory Supervisor stated samples are not refrigerated until checked into the lab due to limited space.

3. **Failure to Follow Written Stability Testing Program:** A review of the Dexamethasone Phosphate 6mg in 25mL NS (0.24mg/mL

Company
QuVa Pharma, Inc.
Inspection date
August 18, 2022
Office
Dallas District Office
Person
  • Camerson E. Moore (Microbiologist)
View Company Profile

ID · 59535d99-826d-4405-be15-8b10bb5cde4f

Violation Codes2
21 U.S.C. 324(a)(4)21 CFR 331(c)

Full citation text and observation details available on the Dashboard.

Other documents for QuVa Pharma, Inc.
  • 483 - 2022-10-14October 14, 2022
  • WARNING_LETTER - 2022-10-14October 14, 2022
  • 483 - 2019-05-31May 31, 2019
  • 483 - 2019-04-23April 23, 2019
  • 483 - 2019-03-14March 14, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore QuVa Pharma, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.